Consistent with these findings, our data suggest that daily treatment with everolimus after injection of anti-Thy1 to induced glomerulonephritis prevented the progression of renal injury and glomerular damage via a reduction in inflammation, oxidative stress and apoptosis and the prevention of the loss of glomerular nephrin as an essential protein for proper function of the glomerular endothelial barrier [25]. The gene discussed is NPHS1; the disease is glomerulonephritis.